Author: Nichols Martin|| Date Published: July 8, 2020
Advanced Technology International has been awarded a one-year, $450.4M contract modification by the U.S. Army to produce antibodies to the virus that causes COVID-19.
The branch obligated the full contract amount for ATI’s large-scale antibody manufacturing efforts, the Department of Defense said Tuesday.
Work will take place in Summerville, S.C., and Tarrytown, N.Y., through June 30 next year.
ATI operates as a nonprofit subsidiary of ANSER and serves government customers through research-and-development collaboratins.
OSIbeyond has introduced a compliance-as-a-service, or CaaS, offering designed to help defense contractors secure and maintain Cybersecurity Maturity Model Certification.…
Raytheon, an RTX business, has received a $206.2 million contract from the U.S. Navy to integrate advanced Global Positioning System capabilities into…
